147 related articles for article (PubMed ID: 9364286)
1. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results.
Delvaux M; Wingate D
J Int Med Res; 1997; 25(5):225-46. PubMed ID: 9364286
[TBL] [Abstract][Full Text] [Related]
2. Trimebutine: a state-of-the-art review.
Salvioli B
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):229-238. PubMed ID: 31617696
[TBL] [Abstract][Full Text] [Related]
3. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome.
Lüttecke K
Curr Med Res Opin; 1980; 6(6):437-43. PubMed ID: 6988171
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
Matsue T; Yamato S; Umeda N
Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
[No Abstract] [Full Text] [Related]
5. A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats.
Distrutti E; Mencarelli A; Renga B; Caliendo G; Santagada V; Severino B; Fiorucci S
Pharmacol Res; 2009 May; 59(5):319-29. PubMed ID: 19416632
[TBL] [Abstract][Full Text] [Related]
6. [Trimebutine. Pharmacology, recent concepts about its mechanism of action, therapeutic results].
Fraitag B; Hostein J; Pascaud X; Junien JL
Gastroenterol Clin Biol; 1992; 16(5):413-20. PubMed ID: 1526395
[No Abstract] [Full Text] [Related]
7. Role of opioid ligands in the irritable bowel syndrome.
Corazziari E
Can J Gastroenterol; 1999 Mar; 13 Suppl A():71A-75A. PubMed ID: 10202212
[TBL] [Abstract][Full Text] [Related]
8. The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.
Boziki M; Grigoriadis N; Papaefthymiou A; Doulberis M; Polyzos SA; Gavalas E; Deretzi G; Karafoulidou E; Kesidou E; Taloumtzis C; Theotokis P; Sofou E; Katsinelos P; Vardaka E; Fludaras I; Touloumtzi M; Koukoufiki A; Simeonidou C; Liatsos C; Kountouras J
Neurochem Int; 2021 Mar; 144():104938. PubMed ID: 33535070
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of trimebutine (Mebutin) in spastic colon.
Moshal MG; Herron M
J Int Med Res; 1979; 7(3):231-4. PubMed ID: 456734
[TBL] [Abstract][Full Text] [Related]
11. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia.
Aktas A; Caner B; Ozturk F; Bayhan H; Narin Y; Mentes T
Ann Nucl Med; 1999 Aug; 13(4):231-4. PubMed ID: 10510878
[TBL] [Abstract][Full Text] [Related]
12. Local actions of trimebutine on canine gastrointestinal tract.
Daniel EE; Kostolanska F; Fox JE
Gastroenterol Clin Biol; 1987; 11(3 Pt 2):86B-88B. PubMed ID: 3038657
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
Long Y; Liu Y; Tong J; Qian W; Hou X
Eur J Pharmacol; 2010 Jun; 636(1-3):159-65. PubMed ID: 20371236
[TBL] [Abstract][Full Text] [Related]
14. [The use of Debridat in treating the irritable bowel syndrome].
Parfenov AI
Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
[No Abstract] [Full Text] [Related]
15. Effect of trimebutine on intestinal motility and plasma motilin in the dog.
Poitras P; Honde C; Havrankova J; Lahaie RG; Trudel L; Goyer R; Junien JL; Pascaud X
Am J Physiol; 1986 Sep; 251(3 Pt 1):G349-53. PubMed ID: 3529986
[TBL] [Abstract][Full Text] [Related]
16. [Effects of trimebutine on intestinal motility in dogs].
Hondé C; Le Gallou B; Pascaud X; Junien JL
Presse Med; 1989 Feb; 18(6):294-7. PubMed ID: 2522226
[TBL] [Abstract][Full Text] [Related]
17. [Effect of trimebutine on the plasma postprandial release of gastrointestinal hormones in the dog].
Poitras P; Hondé C; Goyer R; Junien JL; Pascaud X; Greenberg GR
Gastroenterol Clin Biol; 1987; 11(3 Pt 2):94B-96B. PubMed ID: 3301510
[TBL] [Abstract][Full Text] [Related]
18. [Effects of trimebutine maleate on the gastrointestinal motility in conscious dogs].
Takenaga H; Magaribuchi T; Nosaka K; Tamaki H
Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):271-8. PubMed ID: 7152394
[TBL] [Abstract][Full Text] [Related]
19. Double blind trial of trimebutine in the irritable bowel syndrome.
Fielding JF
Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
[No Abstract] [Full Text] [Related]
20. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
